Free Trial

Poseida Therapeutics (PSTX) Earnings Date, Estimates & Call Transcripts

Poseida Therapeutics logo
$3.08 +0.15 (+5.12%)
(As of 11/8/2024 ET)

Poseida Therapeutics Latest Earnings Summary

Upcoming
Earnings Date
Mar. 6Estimated
Actual EPS
(Aug. 5)
-$0.32 Beat By $0.11
Consensus EPS
(Aug. 5)
-$0.43

Poseida Therapeutics released Q2 2024 earnings on August 5, 2024, reporting an EPS of -$0.32, which topped analysts' consensus estimates of -$0.43 by $0.11. Quarterly revenue was reported to be $25.97 million, above analyst estimates of $13.75 million. With a trailing EPS of -$1.19, Poseida Therapeutics' earnings are expected to decrease next year, from ($1.57) to ($1.97) per share.

PSTX Upcoming Earnings

Poseida Therapeutics' next earnings date is estimated for Thursday, March 6, 2025, based off prior year's reporting schedules.

Get Poseida Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Poseida Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

PSTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PSTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Poseida Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.51-$0.45-$0.48
Q2 20242-$0.43-$0.38-$0.41
Q3 20242-$0.48-$0.33-$0.41
Q4 20242-$0.51-$0.34-$0.43
FY 20248-$1.93-$1.50-$1.72
Q1 20252-$0.56-$0.34-$0.45
Q2 20252-$0.59-$0.48-$0.54
Q3 20252-$0.50-$0.45-$0.48
Q4 20252-$0.52-$0.10-$0.31
FY 20258($2.17)($1.37)($1.77)

Poseida Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/6/2025
(Estimated)
------- 
8/5/2024--$0.43-$0.32+$0.11-$0.32$13.75M$25.97M  
5/14/2024Q1 2024-$0.43-$0.25+$0.18-$0.25$11.25M$28.14M  
3/7/2024Q4 2023-$0.36-$0.27+$0.09-$0.27$12.50M$25.00M  
11/9/2023Q3 2023-$0.29-$0.35 -$0.06-$0.35$11.50M$9.35M  
8/8/2023Q2 2023-$0.53-$0.32+$0.21-$0.32$10.00M$20.01M  
5/9/2023Q1 2023-$0.40-$0.45 -$0.05-$0.45$10.00M$10.34M  
3/9/2023Q4 2022$0.47-$0.39 -$0.86-$0.39$35.00M$10.05M
11/10/2022Q3 2022-$0.68$0.92+$1.60$0.92$2.00M$116.31M

Poseida Therapeutics Earnings - Frequently Asked Questions

Poseida Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based off last year's report dates. Learn more on PSTX's earnings history.

In the previous quarter, Poseida Therapeutics (NASDAQ:PSTX) reported ($0.32) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.43) by $0.11. Learn more on analysts' earnings estimate vs. PSTX's actual earnings.

Poseida Therapeutics (NASDAQ:PSTX) has a recorded annual revenue of $64.70 million.

Poseida Therapeutics (NASDAQ:PSTX) has a recorded net income of -$123.43 million. PSTX has generated -$1.19 earnings per share over the last four quarters.

Poseida Therapeutics's earnings are expected to decrease from ($1.57) per share to ($1.97) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:PSTX) was last updated on 11/8/2024 by MarketBeat.com Staff
From Our Partners